- ¥4bn
- ¥3bn
- ¥16bn
- 67
- 82
- 55
- 80
Annual balance sheet for Scinex, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Tanshin |
| Standards: | JAS | JAS | JAS | JAS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 4,429 | 4,944 | 5,307 | 5,419 | 4,657 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,753 | 1,804 | 1,703 | 1,913 | 2,121 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,349 | 6,998 | 7,277 | 7,605 | 7,061 |
| Net Property, Plant And Equipment | 5,170 | 5,226 | 5,116 | 5,206 | 5,105 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 13,826 | 14,517 | 14,426 | 14,942 | 14,811 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,854 | 2,497 | 2,369 | 2,630 | 2,534 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6,750 | 7,249 | 6,918 | 7,083 | 6,766 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 7,076 | 7,269 | 7,509 | 7,860 | 8,044 |
| Total Liabilities & Shareholders' Equity | 13,826 | 14,517 | 14,426 | 14,942 | 14,811 |
| Total Common Shares Outstanding |